AstraZeneca shareholder believes Pfizer will renew bid

AstraZeneca shareholder Aberdeen Asset Management believes Pfizer will return with a renewed bid for the British drug manufacturer in six months.

ITV News Business Editor Joel Hills reports:


Aberdeen Assert Management (owns 2.5% of AZ) says "has confidence" in board but wants "fuller explanation" and suggests Pfizer may be back.


"I don't think this is the last roll of the dice" - Anne Richards, Chief Investment Officer, AAM believes Pfizer will return in 6 months.

Read: Is Pfizer's failed final bid the end of takeover saga?


Pfizer admits defeat on AstraZeneca bid

US pharmaceuticals giant Pfizer has called off its multi-billion pound bid to take over British-Swedish firm AstraZeneca. The decision came after AstraZeneca's board declined an offer worth almost £70bn.